Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin J Shattock

Showing results (51-60 of 210) with videos related to

Pageof 21
Sort By:
Gene Therapy|July 14, 2019
Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNAAnna K Blakney, Paul F McKay, Bárbara Ibarzo Yus, et al.
Biomacromolecules|April 27, 2018
One Size Does Not Fit All: The Effect of Chain Length and Charge Density of Poly(ethylene imine) Based Copolymers on Delivery of pDNA, mRNA, and RepRNA PolyplexesAnna K Blakney, Gokhan Yilmaz, Paul F McKay, et al.
Virologica Sinica|December 21, 2014
Binding of HIV-1 virions to α4β 7 expressing cells and impact of antagonizing α4β 7 on HIV-1 infection of primary CD4+ T cellsChang Li, Wei Jin, Tao Du, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 30, 2017
Localized cyclical variations in immunoproteins in the female genital tract and the implications on the design and assessment of mucosal infection and therapiesJulia Makinde, Clifford Jones, Angela Bartolf, et al.
Plos One|November 22, 2013
A "prime-pull" vaccine strategy has a modest effect on local and systemic antibody responses to HIV gp140 in miceJohn S Tregoning, Viviana Buffa, Anna Oszmiana, et al.
European Journal of Immunology|November 8, 2011
Thymic stromal lymphopoietin (TSLP) acts as a potent mucosal adjuvant for HIV-1 gp140 vaccination in miceGriet A Van Roey, Mauricio A Arias, John S Tregoning, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 21, 2016
CD71 targeting boosts immunogenicity of sublingually delivered influenza haemagglutinin antigen and protects against viral challenge in miceJamie F S Mann, John S Tregoning, Yoann Aldon, et al.
Vaccine|October 1, 2019
Antigenicity and immunogenicity of HIV-1 gp140 with different combinations of glycan mutation and V1/V2 region or V3 crown deletionMing Fu, Kai Hu, Huimin Hu, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2015
HIV-1 CNS in vitro infectivity models based on clinical CSF samplesBorja Mora-Peris, Alan Winston, Lucy Garvey, et al.
Vaccines|February 26, 2022
Ex Vivo Evaluation of Mucosal Responses to Vaccination with ALVAC and AIDSVAX of Non-Human PrimatesCarolina Herrera, Ronald Veazey, Melissa M Lemke, et al.
Pageof 21

Showing results (51-60 of 210) with videos related to

Sort By:
Pageof 21
Gene Therapy|July 14, 2019
Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNAAnna K Blakney, Paul F McKay, Bárbara Ibarzo Yus, et al.
Biomacromolecules|April 27, 2018
One Size Does Not Fit All: The Effect of Chain Length and Charge Density of Poly(ethylene imine) Based Copolymers on Delivery of pDNA, mRNA, and RepRNA PolyplexesAnna K Blakney, Gokhan Yilmaz, Paul F McKay, et al.
Virologica Sinica|December 21, 2014
Binding of HIV-1 virions to α4β 7 expressing cells and impact of antagonizing α4β 7 on HIV-1 infection of primary CD4+ T cellsChang Li, Wei Jin, Tao Du, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 30, 2017
Localized cyclical variations in immunoproteins in the female genital tract and the implications on the design and assessment of mucosal infection and therapiesJulia Makinde, Clifford Jones, Angela Bartolf, et al.
Plos One|November 22, 2013
A "prime-pull" vaccine strategy has a modest effect on local and systemic antibody responses to HIV gp140 in miceJohn S Tregoning, Viviana Buffa, Anna Oszmiana, et al.
European Journal of Immunology|November 8, 2011
Thymic stromal lymphopoietin (TSLP) acts as a potent mucosal adjuvant for HIV-1 gp140 vaccination in miceGriet A Van Roey, Mauricio A Arias, John S Tregoning, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 21, 2016
CD71 targeting boosts immunogenicity of sublingually delivered influenza haemagglutinin antigen and protects against viral challenge in miceJamie F S Mann, John S Tregoning, Yoann Aldon, et al.
Vaccine|October 1, 2019
Antigenicity and immunogenicity of HIV-1 gp140 with different combinations of glycan mutation and V1/V2 region or V3 crown deletionMing Fu, Kai Hu, Huimin Hu, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2015
HIV-1 CNS in vitro infectivity models based on clinical CSF samplesBorja Mora-Peris, Alan Winston, Lucy Garvey, et al.
Vaccines|February 26, 2022
Ex Vivo Evaluation of Mucosal Responses to Vaccination with ALVAC and AIDSVAX of Non-Human PrimatesCarolina Herrera, Ronald Veazey, Melissa M Lemke, et al.
Pageof 21